According to a recent LinkedIn post from PictorLabs, the company is collaborating with Proscia on a demonstration at the USCAP 2026 conference focused on integrating virtual staining directly into pathology information management systems. The session, scheduled for March 23 from 10:00 to 10:30 a.m. at Booth 201, is described as showcasing single-section pathology, on-demand multi-marker stains, and seamless integration into existing digital workflows.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post further notes that PictorLabs plans to demonstrate a live scan-to-virtual-stain workflow at Booth 749 using a Grundium Ocus 40 slide scanner to generate virtual stains in real time. This focus on flexible deployment, including on-premise options, suggests an attempt to address data security and infrastructure concerns that can be important for hospital systems and large laboratory customers.
From an investor perspective, the emphasis on virtual staining as a shift in how staining operates within digital pathology points to PictorLabs positioning itself as an enabler of more efficient, software-driven lab operations. If adopted, such technology could reduce reliance on traditional wet-lab staining processes, potentially lowering consumables costs for labs and creating recurring software or service revenue opportunities for the company.
The collaboration with Proscia, a digital pathology platform provider, and interoperability with hardware such as the Grundium Ocus 40 scanner indicate an ecosystem-driven strategy rather than a closed solution. This approach may improve PictorLabs’ ability to integrate into existing customer environments, which can be a key factor for scaling deployments and accelerating commercial adoption in the competitive AI-enabled pathology market.